Why Self-collection Is the Means to Maximize Cervical Cancer Screening
There are significant barriers to cervical cancer screening. Sample self-collection promises to improve access to testing and treatment.
There are significant barriers to cervical cancer screening. Sample self-collection promises to improve access to testing and treatment.
A new study reveals that 85% of women would welcome the option to choose between self-sampling and nurse-led HPV cervical screening.
Researchers developed an effective cervical cancer screening method, which detects more cancers and precancerous stages than current methods.
The ASCCP recognized dual-stain biomarkers as an important tech to determine if an HPV infection is transforming into cervical pre-cancer.
Read MoreNaveris Launched an initiative aimed to expand the applications of its circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test.
Read MoreBD partnered with Camtech Health to advance cervical cancer screening by offering women in Singapore the option to self-collect a sample.
Read MoreIn BD’s newest global survey, women reported self-collection would motivate them to have regular cervical cancer screening.
Read MoreResearchers discovered that lymphatic fluid from surgical drains could inform precise treatments for patients with head and neck cancer.
Read MoreRoche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read MoreAbbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read MorePhysically disabled women may encounter barriers to reproductive health care and a lack of timely access to cervical cancer screening.
Read MoreTwo liquid biopsy tests that look for HPV in blood identified patients with a high risk of cervical cancer recurrence after chemoradiation.
Read MoreResearchers developed an electrochemical DNA biosensor which effectively detects HPV-16 and HPV-18, and can diagnose cervical cancer early.
Read MoreScientists at the Montefiore Einstein Cancer Center developed a test for detecting a type of cervical cancer that Pap tests often miss.
Read MoreNew tests offer clinical and technological perspectives on how to measure if recurrence is happening earlier than current blood tests allow.
Read MoreSelf-collection could be an effective way to increase access to screening for cervical cancer, diagnosing the disease earlier.
Read MoreThe College of American Pathologists is updating the 2017 evidence-based practice guideline, “HPV Testing in Head and Neck Carcinomas.”
Read MoreOnly 19% of Saudi Arabian women are diagnosed with stage I cervical cancer where survival rates are highest, according to a new study.
Read More